AspenBio Pharma, Inc.·4

Sep 24, 1:46 PM ET

Hurd Donald R 4

4 · AspenBio Pharma, Inc. · Filed Sep 24, 2012

Insider Transaction Report

Form 4
Period: 2012-09-21
Hurd Donald R
SVP, Chief Commerical Officer
Transactions
  • Purchase

    Common Stock

    2012-09-21$1.99/sh+15,000$29,85015,000 total

Documents

1 file
  • 4
    appy_hurd4.xmlPrimary

    OWNERSHIP DOCUMENT